ALK and neuroblastoma: Genes related to the RAS-ERK1/2 MAPK pathway display somatic alterations in about 5% of sporadic primary NB tumors, with a much higher percentage of alterations (especially in ALK, NRAS and NF1 genes) in relapsed NB samples obtained after chemotherapy [45,46,47].